CD38 and neoplasm: It is interesting that tumor-infiltrating PD-1+ CD3+ CD+ T cells expressed higher levels of both CD69 and HLA-DR than tumor-infiltrating PD-1+ CD38− CD+ T cells (Fig. 4h, j).